RNA_REGULOMICS · The role of non coding RNA in human health and disease
7РП — „Хора“ (Действия „Мария Кюри“)
- Период
- 2012-10-01 → 2016-09-30
- Финансиране от ЕС
- 155 400 €
- Участници
- 3
- Схема
- MC-IRSES
Линиите свързват координатора с партньорите. За проекти отпреди 2014 г. CORDIS не винаги дава точни координати. Тези точки са на ниво град или държава.
Накратко на български
Некодиращите РНК и свързващите се с тях протеини се изследват в контекста на щитовидната жлеза, костите и сърцето. Тези открития помагат за разбирането на развитието на заболявания и създаването на нови маркери за диагностика на инфаркт.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
The role of non coding RNA in human health and disease
RNA_REGULOMICS is a joint Exchange programme between three partner institutions in two European countries (the Institute of Molecular Medicine in Lisbon, Portugal; the University of Naples and Biogem in Naples, Italy) and one partner institution in Brazil, the Sao Paulo State University. The main goal of the programme was to establish collaborative training and joint research initiatives addressing the role of non-coding RNAs in health and disease. Specific scientific objectives were to 1) unravel the role of non-coding RNA and RNA-binding proteins in thyroid development, physiology and pathology; 2) determine how thyroid hormones regulate the transcriptome of osteoblasts derived from adipose stem cells; and 3) determine whether circulating micro RNAs can be used as biomarkers for heart disease. In brief, we have studied a novel long ncRNA termed Thybe1 (for Thyroid bud enriched 1) in the thyroid gland, and a previously uncharacterized RNA-binding protein, DnajC17, which was identified as a putative modifier gene predisposing to hypothyroidism. Furthermore, we optimized protocols for transcriptome analysis and osteoblast differentiation. Finally, we discovered that the ratio between circulating miRNA-122-5p and miRNA-133b is a new prognostic biomarker in acute myocardial infarction. Training activities included the collaborative organization of two workshops and two advanced practical courses, as well as staff exchange of four faculty members from the European partners and secondements of seven early career stage Brazilian researchers who developed joint research projects in Lisbon and Naples.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
RNA molecules have been already proven to be a key target for disease therapy as well as a tool for the development of new drugs. Since the discovery of small non coding RNA (ncRNA) and all the associated phenomena like RNA interference, the possibility of using RNA-based drugs has become a subject of great interest in the pharmaceutical and clinical fields. ncRNA is at the core of many cellular processes and might become an outstanding landmark in the way how we will fight disease in the future.The objective of this exchange programme is to establish collaborative training and joint research initiatives addressing the role of non-coding RNAs in health and disease.The specific scientific aims are:-To unravel the role of non-coding RNA and RNA-binding proteins in thyroid development, physiology and pathology.-To determine whether thyroid hormones affect non-coding RNAs in osteoblasts derived from adipose stem cells.-To determine whether circulating micro RNAs can be used as biomarkers for heart disease.The programme that we propose to implement will significantly expand biomedical research and training across the Brazilian academic community, while providing the European partner institutions expanded opportunities for collaborations in research and post-graduate education.
Оригинален текст от CORDIS (на английски).
Участници
- INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES · LisboaКоординаторПортугалия
- BIOGEM scarl · ARIANO IRPINO (AV)Ниво държаваИталия
- UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II · NapoliИталия
Връзки
Данни: CORDIS, © Европейски съюз